Maxcyte (MXCT) Income from Continuing Operations (2020 - 2026)
Maxcyte (MXCT) reported Income from Continuing Operations of 4750000.0 for Q1 2026, up 53.71% year-over-year from 3090270.73 in Q1 2025, and up 50.5% quarter-over-quarter from 9596000.0 in Q4 2025.
Maxcyte (MXCT) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of Income from Continuing Operations data on file, last reported at 4750000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 4750000.0, up 53.71% year-over-year; the trailing twelve-month figure through Mar 2026 was 39119000.0 (up 6.39% YoY), and the FY2025 annual result was 44630000.0, down 8.71% from the prior year.
- Income from Continuing Operations grew to 4750000.0 in Q1 2026 per MXCT's latest filing, from 9596000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 4067300.0 in Q1 2022 and troughed at 12416000.0 in Q3 2025.
- A 5-year average of 8936988.24 and a median of 9596000.0 in 2025 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2026: Income from Continuing Operations plunged 167.55% in 2023, then surged 53.71% in 2026.
- A 5-year view of Income from Continuing Operations shows it stood at 4809600.0 in 2022, then dropped by 9.74% to 5278000.0 in 2023, then sank by 100.78% to 10597000.0 in 2024, then increased by 9.45% to 9596000.0 in 2025, then soared by 50.5% to 4750000.0 in 2026.
- Business Quant data shows MXCT's Income from Continuing Operations at 4750000.0 in Q1 2026, 9596000.0 in Q4 2025, and 12416000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Maxcyte | 123.44 Mn | 123.44 Mn | 8.08 Mn | -4.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.75 Mn |
| Dec 31, 2025 | -9.60 Mn |
| Sep 30, 2025 | -12.42 Mn |
| Jun 30, 2025 | -12.36 Mn |
| Mar 31, 2025 | -10.26 Mn |
| Dec 31, 2024 | -10.60 Mn |
| Sep 30, 2024 | -11.56 Mn |
| Jun 30, 2024 | -9.38 Mn |
| Mar 31, 2024 | -9.53 Mn |
| Dec 31, 2023 | -5.28 Mn |
| Sep 30, 2023 | -11.25 Mn |
| Jun 30, 2023 | -10.51 Mn |
| Mar 31, 2023 | -10.88 Mn |
| Dec 31, 2022 | -4.81 Mn |
| Sep 30, 2022 | -6.43 Mn |
| Jun 30, 2022 | -8.26 Mn |
| Mar 31, 2022 | -4.07 Mn |
| Dec 31, 2021 | -4.87 Mn |
| Sep 30, 2021 | -2.68 Mn |
| Jun 30, 2021 | -4.42 Mn |